Zydus Lifesciences has informed that Zydus Healthcare (‘ZHL’), a wholly owned subsidiary of the Company, has received demand Order-In-Original (‘O-I-O’) for the F.Y. 2020-21 on the issue pertaining to Input Tax Credit (‘ITC’) and determined tax liability from GST returns for F.Y. 2020-21. The details as required under regulation 30 of Listing Regulations read with SEBI Circular are enclosed.
The above information is a part of company’s filings submitted to BSE.